Goldman Sachs Group is a leading global investment banking, securities, and investment management firm that provides a wide range of financial services to a diverse client base, including corporations, financial institutions, governments, and individuals. The company engages in various activities, including financial advisory services, underwriting of capital market transactions, asset management, and market making in securities and commodities. It is known for its expertise in mergers and acquisitions, risk management, and investment strategy, leveraging its extensive research capabilities and global reach to deliver innovative solutions in an ever-evolving financial landscape. Read More
DETROIT, MICHIGAN - June 16, 2025 ( NEWMEDIAWIRE ) - While being a biotech company can be difficult, it is not impossible. Just look at Jupiter Neurosciences Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company, for evidence. The company, which is developing drugs to treat neuroinflammation, with a current focus on central nervous system or CNS disorders such as Alzheimer's and Parkinson's and rare diseases, is taking a two-prong approach. That enables it to help people long-term and generate recurring revenue in the short-term.
Goldman Sachs has reduced the probability of recession in the next 12 months to 30%, from 35%, and earlier 45% (Reuters). It’s important to note that these projections are conditional on the path of future policies.
Goldman Sachs analysts said in a recent note that the conflict could result in Iran’s 1.75 million barrels per day supply being taken out of the market.
GLASSBORO, N.J., June 12, 2025 (SEND2PRESS NEWSWIRE) -- Rowan Innovation Venture Fund (RIVF) today announced the appointment of Garden State Venture Partners (GSVP) as its new management team, marking a significant milestone in the fund's evolution. This leadership expansion brings together a seasoned group of investment and institutional professionals to lead the fund into its next phase of innovation and impact. - News from Garden State Venture Partners, issued by Send2Press Newswire
The company and its shareholders sold 32 million shares at $27 per share. The IPO price was slightly higher than the earlier marketed range of $24 to $26 per share.
